+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid therapy of chronic graft versus host disease of the liver following allogeneic bone marrow transplantation



Ursodeoxycholic acid therapy of chronic graft versus host disease of the liver following allogeneic bone marrow transplantation



Hepatology 12(4 Part 2): 996




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144917

Download citation: RISBibTeXText


Related references

Prognostic effect on graft-versus-host disease from allogeneic bone marrow transplantation by ursodeoxycholic acid. Hepatology 30(4 Part 2): 326A, 1999

Usefulness of ursodeoxycholic acid for acute hepatic graft versus host disease in allogeneic bone marrow transplantation. Hepatology 24(4 Part 2): 372A, 1996

Evaluation of the prophylactic effect on graft-versus-host disease from allogeneic bone marrow transplantation by ursodeoxycholic acid. Hepatology 28(4 Part 2): 443A, 1998

Bi-Directional Tolerance Following Cadaveric Liver Transplantation for Chronic Graft Versus Host Disease after Allogeneic Bone Marrow Transplantation. Blood 100(11): Abstract No 5363, November 16, 2002

Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation. Bone Marrow Transplantation 14(4): 641-644, 1994

Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. Transplantation 33(2): 168-173, 1982

Prophylaxis of acute hepatic graft-versus-host disease with ursodeoxycholic acid in allogenic bone marrow transplantation. Hepatology 26(4 Part 2): 401A, 1997

Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Japanese Journal of Clinical Hematology 26(1): 20-27, 1985

Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation. Biomedicine and PharmacoTherapy 43(9): 693-697, 1989

Bone scintigraphy pattern of joint chronic graft-versus-host disease after allogeneic bone marrow transplantation. Clinical Nuclear Medicine 34(1): 20-23, 2009

Chronic graft-versus-host disease in gastric biopsies after allogeneic bone marrow transplantation. Laboratory Investigation 80(3): 78A, 2000

Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation Proceedings 22(3): 1336-1338, 1990

Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation. Neuropathology 22(1): 1-8, 2002

Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics. 82(5): 556-563, 1996